Ultrasound to check lungs and blood flow in newborns getting surfactant
Part of Genetic & congenital, Lungs & breathing clinical trials.
This trial uses bedside ultrasound to see how well the lungs and blood flow are working in premature babies who receive surfactant, a medicine that helps their lungs open up.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby is born before 37 weeks of pregnancy.
- Your baby has or is at risk for breathing problems called respiratory distress syndrome.
- The doctor has decided to give your baby surfactant.
- Your baby does not have major birth defects in their lungs or airways.
- Your baby did not need a breathing tube and machine right after birth in the delivery room.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses a lung ultrasound score, a type of ultrasound, to decide when to give surfactant (a medicine that helps lungs work) to premature babies born between 27 and 35 weeks of pregnancy. It aims to reduce the need for more breathing support and avoid side effects.
This study compares two ways of giving surfactant (a lung-coating medicine) to newborns with breathing trouble: LISA (a gentler, less invasive method) versus traditional breathing tube delivery. Researchers will use ultrasound to see how the medicine spreads in each baby's lungs to find the best approach.
This study uses lung ultrasound to see how different ways of giving surfactant (a medicine for breathing problems) affect preterm babies born before 32 weeks. It may help doctors choose the best method for your baby.
This study tests whether giving surfactant medication guided by a lung ultrasound, instead of by X-ray, helps preterm babies with breathing problems get better without needing a breathing tube. Babies in the study receive surfactant through a thin tube while still on non-invasive breathing support.
This trial looks at giving a “surfactant” medicine (a substance that helps keep baby lungs open) to newborns who have serious breathing problems soon after birth. It may help babies with neonatal respiratory distress or acute breathing distress, especially if they’re treated in the early time window.
This trial tests whether giving surfactant (a substance that helps lungs stay open) to premature babies with Respiratory Distress Syndrome (RDS) through a mask on the throat (supraglottic airway) is safe and effective. It may be an option for babies who need extra oxygen but are not on a breathing tube.
Hear when a new Lung Ultrasound trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.